RVTY earnings date and last-quarter result: last quarter beat, P/E 52.64. Updated 2026-07-23.
Revvity (RVTY) Research Hub
Revvity (RVTY) trades on NYSE, US in the Healthcare (Medical - Diagnostics & Research) sector. As of 2026-10-26, shares last closed at 160.39 USD (+1.02%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 52.64, market cap 12.36B. This hub links to the full technical, earnings and options research available for RVTY.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Diagnostics & Research) |
|---|---|
| Exchange | NYSE, US |
| Last close | 160.39 USD (+1.02%) |
| 52-week range | 96.86 USD – 166.25 USD |
| Trend regime | Range |
| 14-day RSI | 64.5 (Bullish) |
| Trailing P/E | 52.64 |
| Market cap | 12.36B |
| Dividend yield | 0.25% |
Available research for RVTY
Covered Call on RVTY: how it works, illustrative setup around the real 160.39 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on RVTY: how it works, illustrative setup around the real 160.39 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on RVTY: how it works, illustrative setup around the real 160.39 USD price, max profit/loss, breakeven and when to use it. Educational.
RVTY technical analysis: range, last 160.39 USD, RSI 64.5, 52w range 96.86 USD–166.25 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is RVTY in?
Revvity (RVTY) is classified under Healthcare (Medical - Diagnostics & Research), listed on NYSE, US.
Is RVTY in an uptrend or downtrend?
As of 2026-10-26, RVTY is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is RVTY's trailing P/E ratio?
RVTY's trailing P/E is 52.64, with a market cap of 12.36B. See the earnings research page for full valuation detail.